Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, MA, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
J Gen Intern Med. 2023 Mar;38(4):865-872. doi: 10.1007/s11606-022-07778-w. Epub 2022 Sep 20.
Engaging people experiencing homelessness or unstable housing in hepatitis C virus (HCV) treatment is critical to achieving HCV elimination.
To describe HCV treatment outcomes, including factors associated with retention through the treatment cascade, for a cohort of individuals treated in a homeless health center in Boston.
Retrospective cohort study.
All individuals who initiated HCV treatment with Boston Health Care for the Homeless Program's HCV treatment program between January 2014 and March 2020 (N = 867).
The primary outcome was sustained virologic response (SVR), defined as an HCV ribonucleic acid (RNA) level ≤ 15 IU/mL at least 12 weeks after treatment completion. We used multivariable logistic regression to examine the association between baseline variables and SVR. Process-oriented outcomes included treatment completion, assessment for SVR, and achievement of SVR.
Of 867 individuals who started HCV treatment, 796 (91.8%) completed treatment, 678 (78.2%) were assessed for SVR, and 607 (70.0%) achieved SVR. In adjusted analysis, residing in stable housing (OR 3.83, 95% CI 1.85-7.90) and age > 45 years old (OR 1.53, 95% CI 1.04-2.26) were associated with a greater likelihood of achieving SVR. Recent drug use (OR 0.63, 95% CI 0.41-0.95) was associated with a lower likelihood of SVR. Age, housing status, and drug use status impacted retention at every step in the treatment cascade.
A large proportion of homeless-experienced individuals engaging in HCV treatment in a homeless health center achieved SVR, but enhanced approaches are needed to engage and retain younger individuals, those with recent or ongoing substance use, or those experiencing homelessness or unstable housing. Efforts to achieve HCV elimination in this population should consider the complex and overlapping challenges experienced by this population and aim to address the fundamental harm of homelessness itself.
让无家可归或住房不稳定的人参与丙型肝炎病毒 (HCV) 治疗对于实现 HCV 消除至关重要。
描述 HCV 治疗结果,包括与治疗级联中保留相关的因素,该研究纳入了在波士顿一家无家可归者健康中心接受治疗的个体队列。
回顾性队列研究。
所有于 2014 年 1 月至 2020 年 3 月期间在波士顿无家可归者医疗保健项目 HCV 治疗项目中开始 HCV 治疗的个体(N=867)。
主要结局是持续病毒学应答 (SVR),定义为治疗完成后至少 12 周时 HCV 核糖核酸 (RNA) 水平≤15IU/mL。我们使用多变量逻辑回归来检验基线变量与 SVR 之间的关系。面向过程的结局包括治疗完成、SVR 评估和 SVR 达标。
在开始 HCV 治疗的 867 名个体中,796 名(91.8%)完成了治疗,678 名(78.2%)接受了 SVR 评估,607 名(70.0%)实现了 SVR。在调整后的分析中,居住在稳定住房中(比值比 3.83,95%置信区间 1.85-7.90)和年龄>45 岁(比值比 1.53,95%置信区间 1.04-2.26)与 SVR 达标更相关。近期药物使用(比值比 0.63,95%置信区间 0.41-0.95)与 SVR 可能性降低相关。年龄、住房状况和药物使用状况在治疗级联的每一步都影响保留率。
在无家可归者健康中心参与 HCV 治疗的大量无家可归经历者实现了 SVR,但需要采取强化措施来吸引和留住年轻个体、近期或持续使用药物的个体、或无家可归或住房不稳定的个体。在这一人群中实现 HCV 消除的努力应考虑到该人群所经历的复杂和重叠的挑战,并旨在解决无家可归本身所带来的根本危害。